Steven L. Stice
Founder at Aruna Bio, Inc.
Profile
Steven L.
Stice is the founder of Aruna Bio, Inc., a company founded in 2003, where he currently holds the title of Director & Chief Scientific Officer.
He also held the position of Director-Regenerative Bioscience Center at the University of Georgia.
Additionally, he worked as a Consultant at BresaGen, Inc. and as Chief Executive & Scientific Officer at Astellas Institute for Regenerative Medicine.
Steven L. Stice active positions
| Companies | Position | Start |
|---|---|---|
Aruna Bio, Inc.
 Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA. | Founder | 2010-01-12 |
Former positions of Steven L. Stice
| Companies | Position | End |
|---|---|---|
| University of Georgia | Corporate Officer/Principal | 2011-07-03 |
| OCATA THERAPEUTICS INC | Chief Executive Officer | - |
| BresaGen, Inc. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Aruna Bio, Inc.
Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA. | Health Services |
| BresaGen, Inc. | Commercial Services |
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
- Stock Market
- Insiders
- Steven L. Stice
